21 December 2015 - The SMC has announced forthcoming submissions for the following medicines: alendronic acid (Binosto), cabazitaxel (Jevtana), ibrutinib (Imbruvica), mepolizumab (Nucala) & vortioxetine hydrobromide (Brintellix).

For more details, go to: http://www.scottishmedicines.org.uk/SMC_Advice/Forthcoming_Submissions/Forthcoming_Submissions?iru=2ICSSBDQBC